MedTrace Logo

Effect of Omega-3 Supplements on Stress, Anxiety, Depression, Memory and Sleep Quality Among Saudis

NCT07157241 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 64

Last updated 2025-09-05

No results posted yet for this study

Summary

This study looked at whether taking omega-3 supplements can help reduce stress, anxiety, depression, and improve memory and sleep quality in Saudi adults who feel highly stressed or anxious. Omega-3 is a healthy fat found in fish oil that may help the brain and mood.

A total of 64 adults took part. They were randomly split into two groups. One group took omega-3 capsules (500 mg EPA + 250 mg DHA) every day for three months. The other group took a placebo (an inactive oil). Neither the participants nor the researchers knew who was taking which capsules to keep the study fair.

Before and after the three months, all participants completed simple questionnaires about their stress, anxiety, depression, sleep, and everyday memory.

The results showed that people who took omega-3 had lower stress, anxiety, and depression scores and reported better sleep quality and memory compared to those who took the placebo.

This suggests that taking omega-3 supplements may help improve mental wellbeing and sleep in people with high stress and anxiety.

Conditions

  • Healthy Adults
  • Anxiety
  • Depression
  • Sleep Quality
  • Everyday Memory
  • Psychological Distress

Interventions

DIETARY_SUPPLEMENT

Intervention

omega-3 capsules with a concentration of 1000 mg/day for three months (NOW Foods- Ultra omega-3 500 EPA/250 DHA).

DIETARY_SUPPLEMENT

Control group (placebo)

corn oil capsule /day for 3 months

Sponsors & Collaborators

  • Umm Al-Qura University

    lead OTHER

Principal Investigators

  • Alaa Qadhi, Ph.D · Umm Al-Qura University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2022-02-27
Primary Completion
2024-02-12
Completion
2024-08-16

Countries

  • Saudi Arabia

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07157241 on ClinicalTrials.gov